These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 21734653)
1. Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus. Lagenaur LA; Sanders-Beer BE; Brichacek B; Pal R; Liu X; Liu Y; Yu R; Venzon D; Lee PP; Hamer DH Mucosal Immunol; 2011 Nov; 4(6):648-57. PubMed ID: 21734653 [TBL] [Abstract][Full Text] [Related]
2. In vivo evaluation of safety and toxicity of a Lactobacillus jensenii producing modified cyanovirin-N in a rhesus macaque vaginal challenge model. Brichacek B; Lagenaur LA; Lee PP; Venzon D; Hamer DH PLoS One; 2013; 8(11):e78817. PubMed ID: 24265721 [TBL] [Abstract][Full Text] [Related]
3. Engineered vaginal lactobacillus strain for mucosal delivery of the human immunodeficiency virus inhibitor cyanovirin-N. Liu X; Lagenaur LA; Simpson DA; Essenmacher KP; Frazier-Parker CL; Liu Y; Tsai D; Rao SS; Hamer DH; Parks TP; Lee PP; Xu Q Antimicrob Agents Chemother; 2006 Oct; 50(10):3250-9. PubMed ID: 17005802 [TBL] [Abstract][Full Text] [Related]
4. Robust vaginal colonization of macaques with a novel vaginally disintegrating tablet containing a live biotherapeutic product to prevent HIV infection in women. Lagenaur LA; Swedek I; Lee PP; Parks TP PLoS One; 2015; 10(4):e0122730. PubMed ID: 25875100 [TBL] [Abstract][Full Text] [Related]
5. Engineering of a human vaginal Lactobacillus strain for surface expression of two-domain CD4 molecules. Liu X; Lagenaur LA; Lee PP; Xu Q Appl Environ Microbiol; 2008 Aug; 74(15):4626-35. PubMed ID: 18539799 [TBL] [Abstract][Full Text] [Related]
6. Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques. Miyake A; Akagi T; Enose Y; Ueno M; Kawamura M; Horiuchi R; Hiraishi K; Adachi M; Serizawa T; Narayan O; Akashi M; Baba M; Hayami M J Med Virol; 2004 Jul; 73(3):368-77. PubMed ID: 15170630 [TBL] [Abstract][Full Text] [Related]
8. Pathogenic consequences of vaginal infection with CCR5-tropic simian-human immunodeficiency virus SHIVSF162P3N. Shakirzyanova M; Tsai L; Ren W; Gettie A; Blanchard J; Cheng-Mayer C J Virol; 2012 Sep; 86(17):9432-42. PubMed ID: 22740397 [TBL] [Abstract][Full Text] [Related]
9. Homeostatic properties of Lactobacillus jensenii engineered as a live vaginal anti-HIV microbicide. Yamamoto HS; Xu Q; Fichorova RN BMC Microbiol; 2013 Jan; 13():4. PubMed ID: 23298379 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express functional two-domain CD4. Chang TL; Chang CH; Simpson DA; Xu Q; Martin PK; Lagenaur LA; Schoolnik GK; Ho DD; Hillier SL; Holodniy M; Lewicki JA; Lee PP Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11672-7. PubMed ID: 12972635 [TBL] [Abstract][Full Text] [Related]
11. Mucosal transmission of pathogenic CXCR4-utilizing SHIVSF33A variants in rhesus macaques. Harouse JM; Tan RC; Gettie A; Dailey P; Marx PA; Luciw PA; Cheng-Mayer C Virology; 1998 Aug; 248(1):95-107. PubMed ID: 9705259 [TBL] [Abstract][Full Text] [Related]
12. A comparison of lower genital tract glycogen and lactic acid levels in women and macaques: implications for HIV and SIV susceptibility. Mirmonsef P; Gilbert D; Veazey RS; Wang J; Kendrick SR; Spear GT AIDS Res Hum Retroviruses; 2012 Jan; 28(1):76-81. PubMed ID: 21595610 [TBL] [Abstract][Full Text] [Related]
13. Anti-HIV and -SIV immunity in the vagina. Miller CJ; Lü FX Int Rev Immunol; 2003; 22(1):65-76. PubMed ID: 12710504 [TBL] [Abstract][Full Text] [Related]
14. T cell-tropic simian immunodeficiency virus (SIV) and simian-human immunodeficiency viruses are readily transmitted by vaginal inoculation of rhesus macaques, and Langerhans' cells of the female genital tract are infected with SIV. Miller CJ; Hu J J Infect Dis; 1999 May; 179 Suppl 3(Suppl 3):S413-7. PubMed ID: 10099109 [TBL] [Abstract][Full Text] [Related]
15. Selection of a simian-human immunodeficiency virus strain resistant to a vaginal microbicide in macaques. Dudley DM; Wentzel JL; Lalonde MS; Veazey RS; Arts EJ J Virol; 2009 May; 83(10):5067-76. PubMed ID: 19279098 [TBL] [Abstract][Full Text] [Related]
16. V3 loop-determined coreceptor preference dictates the dynamics of CD4+-T-cell loss in simian-human immunodeficiency virus-infected macaques. Ho SH; Shek L; Gettie A; Blanchard J; Cheng-Mayer C J Virol; 2005 Oct; 79(19):12296-303. PubMed ID: 16160156 [TBL] [Abstract][Full Text] [Related]
17. Simian-human immunodeficiency virus containing a human immunodeficiency virus type 1 subtype-E envelope gene: persistent infection, CD4(+) T-cell depletion, and mucosal membrane transmission in macaques. Himathongkham S; Halpin NS; Li J; Stout MW; Miller CJ; Luciw PA J Virol; 2000 Sep; 74(17):7851-60. PubMed ID: 10933692 [TBL] [Abstract][Full Text] [Related]
18. Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIV(SF162P3). Harouse JM; Gettie A; Eshetu T; Tan RC; Bohm R; Blanchard J; Baskin G; Cheng-Mayer C J Virol; 2001 Feb; 75(4):1990-5. PubMed ID: 11160699 [TBL] [Abstract][Full Text] [Related]
19. In vivo replication capacity rather than in vitro macrophage tropism predicts efficiency of vaginal transmission of simian immunodeficiency virus or simian/human immunodeficiency virus in rhesus macaques. Miller CJ; Marthas M; Greenier J; Lu D; Dailey PJ; Lu Y J Virol; 1998 Apr; 72(4):3248-58. PubMed ID: 9525652 [TBL] [Abstract][Full Text] [Related]
20. Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239. Miller CJ; McChesney MB; Lü X; Dailey PJ; Chutkowski C; Lu D; Brosio P; Roberts B; Lu Y J Virol; 1997 Mar; 71(3):1911-21. PubMed ID: 9032322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]